Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  582 results for ""Deoxycytidine""

Your Filters

Publication : cancer chemotherapy and pharmacology
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Influence of age on pharmacokinetics of capecitabine and its metabolites in older adults with cancer: a pilot study.

  • Authors : Shafiei M; Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. .; Concord Cancer Centre, Concord Repatriation General Hospital, Hospital Road, Concord, NSW, 2139, Australia. .

Subjects: Deoxycytidine* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Male

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Aug; Vol. 92 (2), pp. 135-139. Date of Electronic Publication: 2023 Jun 23.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Is age just a number? A population pharmacokinetic study of gemcitabine.

  • Authors : Boosman RJ; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. .; Crombag MBS

Subjects: Antimetabolites, Antineoplastic* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives; Aged

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 May; Vol. 89 (5), pp. 697-705. Date of Electronic Publication: 2022 Apr 15.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism.

  • Authors : Liu A; Department of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, People's Republic of China.; Zhou Y

Subjects: Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*genetics ; MicroRNAs/MicroRNAs/MicroRNAs/*genetics

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Aug; Vol. 88 (2), pp. 343-357. Date of Electronic Publication: 2021 May 15.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma.

  • Authors : Mori S; Department of Gastroenterological Surgery, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi, 321-0293, Japan. .; Aoki T

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/*drug therapy

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Jul; Vol. 88 (1), pp. 109-120. Date of Electronic Publication: 2021 Apr 07.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.

  • Authors : Feliu J; Medical Oncology Department, IdiPAZ, CIBERONC, Cátedra UAM-AMGEN, Hospital Universitario La Paz, Paseo de la Castellana 261., 28046, Madrid, Spain. .; Jorge Fernández M

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Albumins/Albumins/Albumins/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Apr; Vol. 87 (4), pp. 543-553. Date of Electronic Publication: 2021 Jan 15.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine.

  • Authors : Soyama H; Departments of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama, 359-8513, Japan.; Miyamoto M

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/administration & dosage ; Bevacizumab*/Bevacizumab*/Bevacizumab*/adverse effects ; Bevacizumab*/Bevacizumab*/Bevacizumab*/pharmacokinetics

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 May; Vol. 85 (5), pp. 941-947. Date of Electronic Publication: 2020 Apr 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors.

  • Authors : Coyne GO'; Division of Cancer Treatment and Diagnosis, National Cancer Institute, 31 Center Drive, Bldg. 31 Room 3A-44, Bethesda, MD, 20892, USA.; Wang L

Subjects: Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/metabolism ; Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/pathology ; Urologic Neoplasms*/Urologic Neoplasms*/Urologic Neoplasms*/metabolism

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 May; Vol. 85 (5), pp. 979-993. Date of Electronic Publication: 2020 Apr 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.

  • Authors : Wang FT; Department of Surgery, Tongji Hospital, Tongji University School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China.; Wang H

Subjects: Autophagy* ; Drug Synergism*; Chloroquine/Chloroquine/Chloroquine/*pharmacology

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Aug; Vol. 86 (2), pp. 221-232. Date of Electronic Publication: 2020 Jul 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis.

  • Authors : Irie H; Department of Gastroenterology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.; Suzuki R

Subjects: Albumins/Albumins/Albumins/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/*drug therapy

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Mar; Vol. 85 (3), pp. 517-523. Date of Electronic Publication: 2019 Nov 05.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function.

  • Authors : Tomimaru Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka E-2, Suita, Osaka, 565-0871, Japan.; Eguchi H

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/*drug therapy ; Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/Carcinoma, Pancreatic Ductal/*radiotherapy

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Mar; Vol. 85 (3), pp. 537-545. Date of Electronic Publication: 2019 Dec 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  582 results for ""Deoxycytidine""